Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | ADH1A | P07327 | 10/20 | 0.36 |
| ▸ | ADH1C | P00326 | 8/20 | 0.36 |
| ▸ | ADH1B | P00325 | 4/20 | 0.36 |
| ▸ | ADH4 | P08319 | 3/20 | 0.36 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | ADH7 | P40394 | 2/20 | 0.32 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL302898 | 1.00 | CA1 (0.39) | CA1CA2ADH1AADH1CADH1B | |
| SCHEMBL2109114 | 1.00 | CA1 (0.39) | CA1CA2ADH1AADH1CADH1B | |
| SCHEMBL93455 | 1.00 | CA1 (0.39) | CA1CA2ADH1AADH1CADH1B | |
| SCHEMBL2110870 | 1.00 | CA1 (0.39) | CA1CA2ADH1AADH1CADH1B | |
| SCHEMBL93205 | 1.00 | CA1 (0.39) | CA1CA2ADH1AADH1CADH1B | |
| SCHEMBL2109558 | 1.00 | CA1 (0.39) | CA1CA2ADH1AADH1CADH1B | |
| SCHEMBL2109541 | 1.00 | CA1 (0.39) | CA1CA2ADH1AADH1CADH1B | |
| SCHEMBL9432 | 1.00 | — | — | |
| SCHEMBL93216 | 1.00 | CA1 (0.39) | CA1CA2ADH1AADH1CADH1B | |
| SCHEMBL3627527 | 1.00 | CA1 (0.39) | CA1CA2ADH1AADH1CADH1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250212873-A1 | VOLATILE HDAC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-07-03 | — | — | US | claimed |
| EP-4482306-A1 | VOLATILE HDAC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-01-01 | — | — | EP | claimed |
| WO-2023192424-A1 | VOLATILE HD AC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS CROSS-REFERENCE TO RELATED APPLICATION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-10-05 | — | — | WO | claimed |
| WO-2018145219-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING ADDICTIONS BY MEANS OF AVERSIVE COUNTERCONDITIONING | SERANI MOSTAZAL JORGE (CL) | 2018-08-16 | — | — | WO | claimed |
| US-4647661-A | Method of preparing ω-lactams, in particular caprolactam | CHIMICA DEL FRIULI S.P.A. (IT) | 1987-03-03 | — | — | US | claimed |
| EP-0197408-A2 | A method of preparing omega -lactams, in particular caprolactam | CHIMICA DEL FRIULI S.p.A. (IT) | 1986-10-15 | — | — | EP | claimed |
| US-20250212873-A1 | VOLATILE HDAC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-07-03 | — | — | US | disclosed |
| CN-111936457-B | Enol ether pro-fragrances | 弗门尼舍有限公司 | 2025-02-25 | — | — | CN | disclosed |
| CN-112752744-B | Alkylenol ether pro-fragrances | 弗门尼舍有限公司 | 2025-02-18 | — | — | CN | disclosed |
| US-20250049660-A1 | ENOL ETHER PROPERFUME | FIRMENICH SA (CH) | 2025-02-13 | — | — | US | disclosed |
| EP-4482306-A1 | VOLATILE HDAC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-01-01 | — | — | EP | disclosed |
| EP-4416125-A1 | ENOL ETHER PROPERFUME | Firmenich SA (CH) | 2024-08-21 | — | — | EP | disclosed |
| CN-118369306-A | Enol ether pro-fragrances | 弗门尼舍有限公司 | 2024-07-19 | — | — | CN | disclosed |
| EP-0434080-A1 | Derivatives of N-hals-substituted amic acid hydrazides | ELF ATOCHEM NORTH AMERICA, INC. (US) | 1991-06-26 | — | — | EP | disclosed |
| US-4129586-A | Peroxide free radical initiators containing ultraviolet light stabilizing groups | PENNWALT CORPORATION (US) | 1978-12-12 | — | — | US | disclosed |
| US-4055714-A | POLYMERIZATION CATALYSTS | PENNWALT CORPORATION (US) | 1977-10-25 | — | — | US | disclosed |
| US-4045427-A | POLYMERIZATION CATALYSTS | PENNWALT CORPORATION (US) | 1977-08-30 | — | — | US | disclosed |
| US-4045426-A | POLYMERIZATION CATALYSTS | PENNWALT CORPORATION (US) | 1977-08-30 | — | — | US | disclosed |
| US-4042773-A | REACTION WITH POLYMERS | PENNWALT CORPORATION (US) | 1977-08-16 | — | — | US | disclosed |
| US-3956269-A | POLYMERIZATION CATALYSTS | PENNWALT CORPORATION (US) | 1976-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250049660-A1 | ENOL ETHER PROPERFUME | CYP2E1, ADH5, ECI1 | CA1 3259/4885CA2 3624/4885ADH1A 10/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.